Eurofins Genomics and Olink partner to advance proteomics research
Drug Discovery World
SEPTEMBER 20, 2023
Eurofins Genomics has adopted Olink technology to advance proteomics research and accelerate its precision medicine programmes. The collaboration is designed to bolster the company’s offerings in the fields of research, population health, and regulated clinical trials. To read this content in full, you need to login.
Let's personalize your content